Amarin Corp. (AMRN) – Business Wire
-
Sarissa Capital Believes Amarin Stock Is Meaningfully Undervalued and Has Increased Its Ownership
-
Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide
-
Sarissa Capital Condemns Amarin Board for Frontrunning Results of Proxy Contest With Egregious Equity Grants to Executives
-
Sarissa Capital Reminds Amarin Shareholders Today Is the Last Day to Vote “FOR” Change
-
Sarissa Capital Urges Amarin Shareholders to Vote “FOR” Necessary Change
-
Sarissa Capital Urges Amarin Shareholders to Vote for Change and Remake Amarin for Shareholders
-
Sarissa Capital Blasts Amarin’s Repeated False Statements; Clearly Amarin Will Say Anything to Keep Sarissa Off the Board
-
Sarissa Capital Uncovers That Amarin’s Registrar Had Not Been Instructed to Accept Blue Proxy Cards Even Though Legally Required to Do So
-
Sarissa Capital Disappointed That Amarin Webcast Continues Board’s Defense of Poor Results and Lack of Accountability
-
Sarissa Capital Warns of Amarin’s Expensive Attempts to Switch Votes by Inundating Shareholders With White Proxy Cards
-
Sarissa Capital Does Not Believe Amarin Cares About Shareholders
-
Sarissa Capital Highlights Amarin’s Inaccurate and Misleading Statements
-
Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin
-
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders
-
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
-
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
-
Sarissa Capital Has Commenced the Process to Call a Special Meeting of Amarin Shareholders to Remove and Replace Certain Board Members
-
Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
-
Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting
-
Cyteir Therapeutics Announces the Appointment of John F. Thero to Board of Directors
-
BYOMass Announces Appointment of Drs. Declan Doogan and Stephen Hoffman to Board of Directors
-
Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers
-
Tenax Therapeutics, Inc. Expands Board of Directors
-
PIC Therapeutics Raises $5 Million to Advance Development of Small Molecules That Selectively Modulate eIF4E
-
Microbiotica Appoints Thomas Lynch as Independent Non-Executive Chairman
Back to AMRN Stock Lookup
